Cooperatieve Rabobank’s Pfizer PFE Stock Holding History

Cooperatieve Rabobank’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,276	Closed	-$273K	–	30
2015 Q1	$273K	Buy	+8,276	New	+$263K	1.3%	27

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Cooperatieve Rabobank's PFE Position: Q2 2015 in Review

Cooperatieve Rabobank sold out of Pfizer (PFE) in Q2 2015, closing a stake of 8,276 shares — an estimated $273K sold.

Cooperatieve Rabobank first reported a position in PFE in Q1 2015 and held it in 1 quarter. The position peaked at $273K in Q1 2015. 1,887 funds tracked by Wall St. Rank hold PFE as of Q2 2015.

Cooperatieve Rabobank reported no remaining Pfizer position as of Q2 2015 after selling out during the quarter.
Cooperatieve Rabobank sold 8,276 Pfizer shares in Q2 2015, an estimated $273K.
Cooperatieve Rabobank first reported a position in Pfizer in Q1 2015 and held it in 1 quarter.
Cooperatieve Rabobank's Pfizer position peaked at $273K in Q1 2015.
1,887 funds tracked by Wall St. Rank held Pfizer as of Q2 2015.

Based on Cooperatieve Rabobank's 13F filing for Q2 2015, filed 14 Aug 2015.